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Abstract
Background: Centralisation of specialist surgical services requires that patients are referred to a regional centre for
surgery. This process may disadvantage patients who live far from the regional centre or are referred from other
hospitals by making referral less likely and by delaying treatment, thereby allowing tumour progression. The aim of
this study is to explore the outcome of surgery for peri-ampullary cancer (PC) with respect to referring hospital and
travel distance for treatment within a network served by five hospitals.
Methods: Review of a unit database was undertaken of patients undergoing surgery for PC between January 2006
and May 2014.
Results: 394 patients were studied. Although both the median travel distance for patients from the five hospitals
(10.8, 86, 78.8, 54.7 and 89.2 km) (p < 0.05), and the annual operation rate for PC (2.99, 3.29, 2.13, 3.32 and 3.07 per
100,000) (p = 0.044) were significantly different, no correlation was noted between patient travel distance and
population operation rate at each hospital. No difference was noted between patients from each hospital in terms
of resection completion rate or pathological stage of the resected tumours. The median survival after diagnosis for
patients referred from different hospitals ranged from 1.2 to 1.7 years and regression analysis revealed that
increased travel distance to the regional centre was associated with a small survival advantage.
Conclusion: Although variation in the provision and outcome of surgery for PC between regional hospitals is
noted, this is not adversely affected by geographical isolation from the regional centre.
Trial registration: This study is part of post-graduate research degree project. The study is registered with
ClinicalTrials.gov (unique identifier NCT02296736) November 18, 2014.
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Background
Since publication of the Improving Outcomes Document
in September 2000 [1] surgery for periampullary cancer
(PC) in the UK has been centralised into designated
regional Hepato-Pancreatico-Biliary (HPB) centres, each
serving a population of approximately two million. This
process requires that most hospitals do not undertake
pancreatic resection, but perform the initial treatment
and assessment of patients with potential PC, before re-
ferral to the regional tertiary centre. This separation of
secondary from tertiary care in different hospitals has
the potential to disadvantage patients referred from
hospitals other than the regional centre, as the referral
process is likely to be more complex than when sec-
ondary and tertiary care are provided on the same site.
Inevitably provision of pancreatic surgical services in a
single HPB centre within a large area will impose
greater difficulty and inconvenience for some patients
in travelling to the regional centre, which may adversely
affect referral for treatment for patients with PC.
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Furthermore delays in treatment for patients residing
further from the regional centre may allow tumour pro-
gression and have an adverse effect on outcomes.
The potential influence of referral between hospitals
and geographical isolation on the outcome of surgery for
PC has not been assessed and the aim of this study is to
assess associations between referring hospital of origin
and traveling distance to the regional HPB surgical
centre with the population rate of surgery for PC, the
interval to surgery, pathological outcome and long-term
survival after diagnosis of PC within a cancer network.
Methods
The Peninsula HPB unit provides pancreatic surgical
services to the Peninsula Cancer Network, which serves
the largely rural UK counties of Devon and Cornwall,
ranking the 7th and 12th least densely populated of 90
English local government areas [2]. The population of
the two counties (1.67 million) is served by four hospi-
tals providing secondary care only, and one hospital
which provides secondary care and also hosts the re-
gional tertiary HPB surgery centre. Surgery and imme-
diate post-operative care are provided by the regional
centre. All other treatment including stent insertion,
adjuvant chemotherapy and long-term follow-up are
provided by local hospitals. All hospitals are linked by a
weekly audio-visual MDT with the regional centre. Re-
ferral and transfer of patients follows agreed protocols
and is coordinated by nurse specialists.
Details of a consecutive series of patients having sur-
gery at the Peninsula HPB unit between January 2006
and May 2014 were studied. Demographic, operative
and pathology data were retrieved from the unit data-
base. Included patients were those who underwent sur-
gery for PC where final histology revealed a diagnosis
of pancreatic, ampullary, distal bile duct or duodenal
adenocarcinoma, or those where resection could not be
completed and intra-operative biopsy confirmed the
presence of adenocarcinoma. Patients receiving neo-
adjuvant chemotherapy were excluded. The size of the
catchment area served by each of the hospitals in the
Peninsula was obtained from South West Public Health
Observatory [3]. The travel distance by road for each
patient was obtained from the AA mileage calculator
(with permission) using post-code data [4]. The interval
to surgery was calculated from the date of diagnosis of
PC, which was taken as the date of the first cross-
sectional abdominal imaging which suggested this diag-
nosis. The presence of biliary obstruction was defined
as either clinically evident jaundice at the time of surgery
or the requirement for pre-operative biliary drainage. Pre-
operative diabetes was defined as the requirement for
hypoglycaemic medication. The workload in the HPB sur-
gical centre is shared non-selectively by four surgeons and
is undertaken using standardised techniques, and in-
patient care follows a standard protocol. The American
Society of Anaesthesiologists (ASA) grade was determined
at the time of surgery by the responsible anaesthetist.
Resected specimens were analysed according to Royal
College of Pathologists guidelines [5] and the TNM
classification systems [6] was used to describe patho-
logical stage. Survival data were obtained from hospital
and general practice records and included all deaths oc-
curring after surgery, including in-hospital mortality.
Survival times were calculated to include the interval
prior to surgery and therefore were taken from the date
of the first cross-sectional image which raised the
suspicion of PC. Survival data for the whole group of
patients referred from each hospital is given as single
outcome of interest and is reported as median and
range. Follow-up was completed 1st May 2015.
Differences in demographics, operation rates, travel
distance, interval to surgery and pathology outcome
were compared between hospitals (pathology results for
patients with duodenal cancer were not included due to
low numbers). Difference in discrete variables was
assessed by Pearson Chi square test and continuous vari-
ables by Kruskal-Wallis test. Correlation was assessed by
Spearman correlation coefficient. To explore potential
associations with patient survival a Cox regression ana-
lysis of pre-operative factors including age, gender, ASA
grade, travel distance and the presence of biliary ob-
struction at presentation was undertaken. In addition,
patient survival across five hospitals was compared using
Kaplan–Meier survival curves and between hospital
pairs by Cox regression analysis.
Results
During the study period 394 patients fulfilling the study
criteria underwent surgery to attempt resection of PC at
the regional HPB surgery centre (hospital A) (Fig. 1).
The median age (66.7 years, range 39.4- 86.4) and gen-
der mix (56.3% male) of the whole group did not vary
between patients referred from hospital A, or from hos-
pitals providing secondary care only (hospital B to E)
(Table 1). The number of operations for PC undertaken
as a proportion of the local population however varied
significantly between referring hospitals (Table 1). The
median distance patients were required to travel for care
was 61.4 km and was significantly less for patients re-
ferred from within the catchment area of the regional
HPB surgery centre to that for patients referred from all
other hospitals in the Peninsula. No correlation was
noted between the median travel distance to the regional
centre of patients from the referring hospitals and the
operation rate at that hospital (p = .855). The second
lowest population operation rate was noted from the
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population receiving secondary care from the hospital
hosting the regional HPB centre.
The distribution of ASA grades, the proportion of pa-
tients with diabetes, biliary obstruction at the time of
surgery and pre-operative biliary intervention did not
differ between hospitals (Table 1). The median interval
from first investigation suggesting a diagnosis of PC to
surgery was 49 days (interquartile range 34–69 days)
and was similar between referring hospitals. Correlation
analysis revealed no association between the travel
Study Group
n= 394
Resected
n= 273
Duodenal
adenocarcinoma
n= 8
(2.9%)
Unresectable at
surgery
n= 121
Bile Duct
adenocarcinoma
n= 46
(16.8%)
Ampullary 
adenocarcinoma
n= 70
(25.6%)
Pancreatic
adenocarcinoma
n= 149
(54.6%)
Fig. 1 Patients undergoing surgery for PC at Peninsula HPB Centre between January 2006 and May 2014
Table 1 Details of 394 patients undergoing surgery for peri-ampullary cancer between January 2006 and May 2014, displayed by
referring hospital of origin. Hospital A hosts the regional HPB cancer centre
Referring hospital (A) (B) (C) (D) (E) P
n = 394 (%) 111 (28.2) 97 (24.6) 70 (17.8) 74 (18.8) 42 (10.6)
Population served 464,437 368,313 410,213 278,555 171,227
Annual operation rate for PC per 100000 2.99 3.29 2.13 3.32 3.07 0.044
Median Travel Distance (kilometres) (range) 10.8 (2.4–112) 85.9 (45.2–155.8) 78.8 (10.1–130.3) 54.7 (2.4–96.2) 98.3 (63–138.6) .000
Median age (range) 65.7 (41.2–82.0) 68.4 (41.7–84.0) 65.5 (39.4–78.6) 65.6 (45.9–86.4) 70.2 (50.7–84.4) .105
Gender (% Male) 53.2 58.8 58.6 58.1 52.4 .880
ASA Grade (%) 1 8 (7.2) 8 (8.2) 8 (11.4) 7 (9.5) 0 .416
2 56 (50.5) 53 (54.6) 39 (55.7) 41 (55.4) 22 (52.4)
3 28 (25.2) 26 (26.8) 18 (25.7) 18 (24.3) 14 (33.3)
4 2 (1.8) 1 (1) 0 0 0
Missing 17 (15.3) 9 (9.3) 5 (7.1) 8 (10.8) 6 (14.3)
Diabetes Yes (%) 13 (11.7) 10 (10.3) 7 (10.0) 6 (8.1) 5 (11.9) .987
Missing data 12 (10.8) 17 (17.5) 14 (20.0) 15 (20.3) 4 (9.5)
Jaundice at Presentation (%) 91 (82.0) 82 (84.5) 56 (80) 65 (87.8) 36 (85.7) .641
Median interval to surgery (days) (range) 47 (5–551) 52 (1–459) 56.5 (16–379) 47 (16–246) 51.5 (6–477) .108
Resection completed (%) 73 (65.7) 68 (70) 51 (72.8) 51 (68.9) 30 (71.4) .880
30-day mortality (%) 4 (3.6) 1 (1) 2 (2.8) 1 (1.3) 2 (4.7) .610
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distance to the regional HPB surgery centre and the
interval to surgery (p = .15). In-patient 30-day mortality
occurred in 10 (2.5%) patients and did not differ be-
tween hospitals.
Tumour resection was completed in 273 patients
(69.3%) and the completion rate did not differ between
hospitals (Table 2). In 121 patients the tumour was inop-
erable at the time of surgery either due to the presence
of vascular invasion (70) or distant metastases (47). In
four patients the reason for irresectability was not re-
corded. Histological diagnoses of the resected specimens
are shown in Fig. 1. Analysis of pathological outcomes
revealed no difference between patients from the referral
zone of the regional centre and those from other hospi-
tals in the region, in terms of resection completion rate,
tumour size, nodal status and resection margin status
(Table 2). Similarly the distribution of the main diagno-
ses of PC did not differ between patients from the re-
gional centre and those from other hospitals.
After a median follow-up of 4.5 years (1.3–9.5 years)
the median survival (range) of the study group was
1.45 (0.11 – 9.4) years and was similar in males (1.44,
0.13–9.3 years) and females (1.45, 0.11–8.7 years).
Two patients were lost to follow-up. Survival was
greater in patients where resection was completed
(1.85, 0.14–9.4 years) than in those where the tumour
could not be removed (0.9, 0.11–2.8 years). The me-
dian survival of patients travelling more than the me-
dian distance for treatment was 1.5 (0.14–8.7) years
compared to 1.4 (0.11–9.4) years for those travelling less
than the median travel distance (p = 0.234). Cox regression
analysis of the association of pre-operative variables in-
cluding individual patient travel distance however revealed
a significant survival advantage associated with increased
travel distance to the regional HPB centre (Table 3).
Further survival analysis revealed that the referring
hospital of origin was associated with outcome (Fig. 2),
with median survival ranging from 1.2 (0.14–6.4) years
(patients from hospital D) to 1.5 (0.3–8.8) years (patients
from hospital B). Pair by pair regression analysis com-
paring patients from the catchment area of the regional
HPB centre revealed no difference in survival from diag-
nosis for patients from three hospitals C, D and E, but
confirmed the significantly decreased hazard ratio of
death of patients referred from hospital B (Table 4).
Discussion
The main findings of this study are: 1) within the Penin-
sula Cancer Network the population operation rate for
PC varies significantly between hospital catchment areas
but this variation is not related to travel distance to the
regional HPB surgical centre and 2) individual patient
travel distance to the regional centre does not adversely
affect the time to surgery, pathological outcome or sur-
vival in patients with PC and 3) the provision of second-
ary and tertiary care in different hospitals does not
adversely affect patient outcomes.
Table 2 Histopathological stage for 265 patients undergoing resection of pancreatic, ampullary and distal bile duct cancer at the
regional HPB centre (A) displayed by referring hospital of origin
N = 265 A
111
B
97
C
70
D
74
E
42
P
Pancreatic cancer (n = 149) 40 38 22 28 21
T size (mm) (range) 30 (15–48) 31.50 (16–60) 30.5 (15–70) 32.5 (12–50) 30 (18–65) .620
N1disease (%) 35 (87.5) 33 (86.8) 19 (86.4) 23 (82.1) 17 (81) .940
R1 resection (%) 34 (85) 24 (63.1) 18 (81.8) 24 (85.7) 19 (90.5) .052
Ampullary cancer (n = 70) 21 18 12 13 6
T size (mm) (range) 25 (12–80) 22.5 (5–65) 23.5 (15–60) 22 (11–65) 28 (8–50) .933
N1disease (%) 14 (66.6) 10 (55.5) 6 (50) 5 (38.5) 4 (66.6) .551
R1 resection (%) 7 (33.3) 1 (5.5) 2 (16.6) 2 (15.4) 2 (33.3) .230
Bile duct cancer (n = 46) 10 10 13 10 3
T size (mm) (range) 25.5 (10–70) 27 (10–45) 25 (10–40) 20 (12–50) 15 (12–20) .216
N1disease (%) 7 (70) 7 (70) 4 (30.7) 7 (70) 1 (33.3) .172
R1 resection (%) 5 (50) 6 (60) 5 (38.5) 5 (50) 2 (66.6) .839
Table 3 Cox regression analysis of potential association of pre-
operative factors including travel distance to regional HPB
centre with survival after diagnosis for 394 patients undergoing
surgery for periampullary cancer
Hazard Ratio Lower .95 Upper .95 P-value
Gender 0.956 0.744 1.229 0.728
Age 1.009 0.995 1.022 0.217
Distance (km) 0.996 0.993 0.999 0.029
Jaundice 0.967 0.686 1.364 0.852
ASA 1 vs 2 0.945 0.678 1.317 0.739
2 vs 3 & 4 1.117 0.888 1.407 0.344
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Centralisation of pancreatic surgical services has led
to improved outcomes including higher resection rates
[7, 8], lower operative mortality [9, 10] and improved
long-term survival [11]. Similar improvements with cen-
tralisation have been noted for liver [12], oesophageal [13],
complex urological [14] and vascular surgery [15]. Despite
these findings the population benefits of regionalisation
are more difficult to demonstrate. Although studies
using hospital data have demonstrated improved out-
comes associated with centralisation of surgical services
for patients who receive treatment [8, 16, 17], these
studies may be biased by selection of patients at the
regional centres and do not take into account patients
who are not referred for treatment. Studies demonstrat-
ing improved population outcomes as a result of re-
gionalisation of complex surgery are more difficult to
undertake. The potential disadvantages of centralisation
of services include a more complex referral pathway
when secondary and tertiary care are provided in differ-
ent hospitals, and an increased burden of travel for
patients living further from the centre, which may dis-
courage referral and attendance for treatment. These
consequences of centralisation have been noted [18, 19]
and the potential risk is greatest in areas of dispersed
population. This has led to controversy over the imple-
mentation of centralisation of surgical services in rural
communities [20], where the risk of limitation of access
due to distance may outweigh the benefit of improved
technical outcomes. The observation that operation
rates are not adversely affected by distance to the HPB
surgical centre, or by referral from a different hospital,
and that travel distance itself does not influence the
outcome of surgery for PC are important, as they show
that regionalisation of surgical services does not neces-
sarily lead to limitations in access or increased patient
selection at the HPB surgical centre.
The small variation in operation rate noted between
hospitals may reflect differences in levels of comorbidity
and suitability for surgery, but may be due to different re-
ferral practices within each hospital. The observation that
the referring hospital of origin is also associated with
long-term survival after surgery for PC is therefore an in-
teresting new finding. Many factors contribute to variation
in local survival rates and levels of comorbidity are likely
to play a major role. It is interesting to note however that
long-term survival is lowest in patients from the hospital
with the highest population rate of surgery for PC. This
may result from referral of more marginal cases, which is
not revealed by the measures of comorbidity and tumour
burden used in this study. Variation in population oper-
ation rate for PC may also explain some of the variation
noted in outcome between high-volume hospitals under-
taking pancreatic surgery [21].
The strength of this analysis lies in the accurate collection
of individual travel distance to the regional HPB surgery
centre in a large consecutive series, and its correlation with
prospectively audited outcomes. In this study a single
measure of survival of all patients has been used, without
division by diagnosis, to allow simple comparison between
hospitals. This figure includes deaths due to surgical com-
plications, which accounts for the short survival in some
patients. A weakness of the study lies in the characterisa-
tion of comorbidity. A more discriminating scoring system
is required to investigate the potential association of co-
morbidity with variations in population operation rate for
PC. The relatively long median interval to surgery noted in
this study, even for patients with biliary obstruction
(47 days), is accounted for by the increasing complexity in
the patient pre-operative pathway. This pathway however
imposes a similar interval to surgery on patients regardless
of geographical isolation from the regional centre. In a
small number of patients a long interval to surgery was due
Number at risk
hospital/years 0 2 4 6 8
A 111 37 9 7 4
B 97 38 18 7 2
C 70 30 13 7 2
D 74 17 4 1 0
E 42 18 6 1 0
Fig. 2 Survival from diagnosis of 394 patients undergoing surgery
for periampullary cancer at Peninsula HPB surgery centre between
January 2006 and May 2014, according to hospital of referral (p = 0.032)
Table 4 Paired regression analysis of association of hospital of
referral (B to E) with survival compared to referral from Hospital
A among 394 patients undergoing surgery for peri-ampullary
cancer
A vs Hazard Ratio Lower .95 Upper .95 P-value
B 0.6934 0.5011 0.9594 0.0271
C 0.7042 0.4952 1.0013 0.0508
D 1.1121 0.7983 1.5493 0.5299
E 0.8228 0.5435 1.2456 0.3565
The data bolded shows a significant findings
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to investigations being undertaken in patients with self-
resolving jaundice, which was not pursued due to patient
improvement.
Conclusion
This study confirms that centralisation of HPB surgical ser-
vices can be implemented without imposing disadvantage
in surgical outcomes on patients due to travel distance to
the HPB surgical centre or referral between hospitals for
treatment.
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